iRhythm Technologies, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. The company is headquartered in San Francisco, California and currently employs 2,000 full-time employees. The company went IPO on 2016-10-20. The firm designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. The company offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. The company offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Mr. Quentin Blackford is the President of iRhythm Holdings, Inc, joining the firm since 2021.
What is the price performance of IRTC stock?
The current price of IRTC is $130.1, it has increased 1.54% in the last trading day.
What are the primary business themes or industries for iRhythm Holdings, Inc?
iRhythm Holdings, Inc belongs to Health Care industry and the sector is Health Care
What is iRhythm Holdings, Inc market cap?
iRhythm Holdings, Inc's current market cap is $4.2B
Is iRhythm Holdings, Inc a buy, sell, or hold?
According to wall street analysts, 16 analysts have made analyst ratings for iRhythm Holdings, Inc, including 9 strong buy, 10 buy, 3 hold, 0 sell, and 9 strong sell